Company Filing History:
Years Active: 2002-2008
Title: Alessandra Blasina: Innovator in Human Checkpoint Kinase Research
Introduction
Alessandra Blasina is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of human checkpoint kinases. With a total of 3 patents to her name, her work has the potential to impact therapeutic approaches in cancer treatment.
Latest Patents
Among her latest patents is the invention related to the human checkpoint kinase gene, hCDS1. This invention comprises the nucleic acid sequence of residues 66-1694 of SEQ ID NO: 1, along with a protein expressed from the gene, fragments, and functional equivalents of the protein. Additionally, the invention provides for pharmaceutical compositions that include the hCDS1 protein, as well as methods utilizing this protein. Another patent focuses on the translated protein, compositions, methods, and kits associated with hCDS1, further showcasing her innovative contributions to the field.
Career Highlights
Alessandra Blasina is affiliated with The Scripps Research Institute, where she conducts her research and development. Her work at this esteemed institution has allowed her to explore groundbreaking ideas and contribute to advancements in medical science.
Collaborations
Some of her notable coworkers include Walter H M L Luyten and Andrew E Parker. Their collaboration has likely fostered an environment of innovation and shared expertise in their research endeavors.
Conclusion
Alessandra Blasina's work in the field of human checkpoint kinases exemplifies her dedication to advancing medical science through innovation. Her patents and research contributions are paving the way for new therapeutic strategies in cancer treatment.